Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Oguogho

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|February 24, 2001
Isoprostanes in atherosclerosisA Oguogho, H Sinzinger
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 6, 2000
LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2alphaA Oguogho, A Ferlitsch, H Sinzinger
Wiener Klinische Wochenschrift|March 27, 1999
Increased plasma, serum and urinary 8-epi-prostaglandin F2 alpha in heterozygous hypercholesterolemiaA Oguogho, M Mehrabi, H Sinzinger
Wiener Klinische Wochenschrift|January 1, 1996
[Single passive smoking exposure induces no measurable oxidation of low density lipoproteins]A Oguogho, H Kritz, H Sinzinger
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 15, 2000
Eicosanoid generation and responsiveness of human lymphatics in hyperlipoproteinemiaA Oguogho, J Kaliman, H Sinzinger
Lymphology|April 19, 2000
Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared with non-smokersH Sinzinger, J Kaliman, A Oguogho
Lymphology|February 9, 1999
Levels of eicosanoids (6-oxo-PGF1 alpha and 8-epi-PGF2 alpha) in human and porcine lymphatics and lymphA Oguogho, J Kaliman, H Sinzinger
Lymphology|October 6, 1997
Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphaticsH Sinzinger, A Oguogho, J Kaliman
Lymphology|July 18, 2000
Prostaglandin synthesis in human lymphatics from precursor fatty acidsA Oguogho, A A Aghajanian, H Sinzinger
VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
[Isoprostanes, a new substance group in angiology--of future significance?]A A Aghajanian, A Oguogho, H Sinzinger
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|February 24, 2001
Isoprostanes in atherosclerosisA Oguogho, H Sinzinger
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 6, 2000
LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2alphaA Oguogho, A Ferlitsch, H Sinzinger
Wiener Klinische Wochenschrift|March 27, 1999
Increased plasma, serum and urinary 8-epi-prostaglandin F2 alpha in heterozygous hypercholesterolemiaA Oguogho, M Mehrabi, H Sinzinger
Wiener Klinische Wochenschrift|January 1, 1996
[Single passive smoking exposure induces no measurable oxidation of low density lipoproteins]A Oguogho, H Kritz, H Sinzinger
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 15, 2000
Eicosanoid generation and responsiveness of human lymphatics in hyperlipoproteinemiaA Oguogho, J Kaliman, H Sinzinger
Lymphology|April 19, 2000
Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared with non-smokersH Sinzinger, J Kaliman, A Oguogho
Lymphology|February 9, 1999
Levels of eicosanoids (6-oxo-PGF1 alpha and 8-epi-PGF2 alpha) in human and porcine lymphatics and lymphA Oguogho, J Kaliman, H Sinzinger
Lymphology|October 6, 1997
Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphaticsH Sinzinger, A Oguogho, J Kaliman
Lymphology|July 18, 2000
Prostaglandin synthesis in human lymphatics from precursor fatty acidsA Oguogho, A A Aghajanian, H Sinzinger
VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
[Isoprostanes, a new substance group in angiology--of future significance?]A A Aghajanian, A Oguogho, H Sinzinger
Pageof 3